Pyrogen Testing Market Size, Share & Trends Report

Pyrogen Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Test Type (LAL Test, In Vitro Pyrogen Test, Rabbit Test), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-706-3
Number of Pages: 90
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Product Outlook (Revenue in USD Million, 2018 - 2030)
- Consumables
- Instruments
- Services
Test Type Outlook (Revenue in USD Million, 2018 - 2030)
- LAL test
  - Chromogenic test
  - Turbidimetric test
  - Gel clot test
- In vitro pyrogen test
- Rabbit test
End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceutical & biotechnology companies
- Medical devices companies
- Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Consumables
    - Instruments
    - Services
  - North America Test Type Outlook (Revenue in USD Million, 2018 - 2030)
    - LAL test
      - Chromogenic test
      - Turbidimetric test
      - Gel clot test
    - In vitro pyrogen test
    - Rabbit test
  - North America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnology companies
    - Medical devices companies
    - Others
  - U.S.
    - U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - U.S. Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Canada
    - Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Canada Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
- Europe
  - Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Consumables
    - Instruments
    - Services
  - Europe Test Type Outlook (Revenue in USD Million, 2018 - 2030)
    - LAL test
      - Chromogenic test
      - Turbidimetric test
      - Gel clot test
    - In vitro pyrogen test
    - Rabbit test
  - Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnology companies
    - Medical devices companies
    - Others
  - Germany
    - Germany Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Germany Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - UK
    - UK Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - UK Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - France
    - France Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - France Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - France End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Italy
    - Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Italy Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Spain
    - Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Spain Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Denmark
    - Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Denmark Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Sweden
    - Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Sweden Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Norway
    - Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Norway Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Consumables
    - Instruments
    - Services
  - Asia Pacific Test Type Outlook (Revenue in USD Million, 2018 - 2030)
    - LAL test
      - Chromogenic test
      - Turbidimetric test
      - Gel clot test
    - In vitro pyrogen test
    - Rabbit test
  - Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnology companies
    - Medical devices companies
    - Others
  - China
    - China Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - China Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - China End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Japan
    - Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Japan Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - India
    - India Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - India Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - India End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Thailand
    - Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Thailand Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - South Korea
    - South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - South Korea Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Australia
    - Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Australia Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
- Latin America
  - Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Consumables
    - Instruments
    - Services
  - Latin America Test Type Outlook (Revenue in USD Million, 2018 - 2030)
    - LAL test
      - Chromogenic test
      - Turbidimetric test
      - Gel clot test
    - In vitro pyrogen test
    - Rabbit test
  - Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnology companies
    - Medical devices companies
    - Others
  - Brazil
    - Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Brazil Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Mexico
    - Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Mexico Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Argentina
    - Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Argentina Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
- Middle East and Africa
  - Middle East and Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Consumables
    - Instruments
    - Services
  - Middle East and Africa Test Type Outlook (Revenue in USD Million, 2018 - 2030)
    - LAL test
      - Chromogenic test
      - Turbidimetric test
      - Gel clot test
    - In vitro pyrogen test
    - Rabbit test
  - Middle East and Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnology companies
    - Medical devices companies
    - Others
  - South Africa
    - South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - South Africa Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Saudi Arabia Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - UAE
    - UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - UAE Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others
  - Kuwait
    - Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Consumables
      - Instruments
      - Services
    - Kuwait Test Type Outlook (Revenue in USD Million, 2018 - 2030)
      - LAL test
        
        Chromogenic test
        
        Turbidimetric test
        
        Gel clot test
      - In vitro pyrogen test
      - Rabbit test
    - Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnology companies
      - Medical devices companies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.